The Latest Articles
Access the latest medical articles in your specialty
The Conference Center
Discover medical conferences through maps, event descriptions, conference coverage, and interviews.
The Clinical Trial Navigator
Find Clinical Trials by Location, Trial Phase, and Ratings.
The Mobile App Center
Read our unbiased reviews of medical apps
The Product Center
Get the latest information on new drugs, equipment, devices, and procedures
The Washington Report
The latest policy changes and public health concerns from government agencies involved in healthcare and medicine.
Are You the Smartest Doc in America?
Sharpen your clinical knowledge and compete with other physicians
Review 1000s of questions based on clinical literature and track your progress over time
Are You Prepared for the Boards?
Prepare for board reviews with confidence with 1000s of board exam style questions
Apply and track your progress.
Post your CV to allow recruiters and employers to contact you about new job opportunities
Search our comprehensive hospital listings
More Physicians. More Candidates.
Your job is hard. Finding the RIGHT physician should not be.
Have an Account?
Create a New Account
American Journal of Clinical Pathology, 05/21/2012Lin CK et al.
The expression of LMX1A may be an independent prognostic risk factor in mucinous cystadenocarcinoma and a helpful marker in evaluating this tumor’s aggressiveness.
Significance of mTOR in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil
See the Latest Medical News from Government Agencies
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.
2015 © M3 USA. ALL Rights Reserved.
Don't Have Account? Sign Up here.
Please submit one of the following: